COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

IMARA, Adapting SiHLE for Detained African American Adolescent Females (IMARA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00746369
Recruitment Status : Completed
First Posted : September 4, 2008
Last Update Posted : November 19, 2013
Centers for Disease Control and Prevention
Information provided by (Responsible Party):
Ralph J. DiClemente, Emory University

Brief Summary:
The IMARA Program will test the efficacy of a multi-session HIV Prevention program, adapted from an existing program(SiHLE), for incarcerated African American adolescent females.

Condition or disease Intervention/treatment Phase
HIV Infections Behavioral: IMARA HIV Prevention Intervention Not Applicable

Detailed Description:

African American adolescent females in youth detention centers are at high risk for HIV infection. There are, however, no evidence-based interventions (EBI) for this vulnerable population. The aim of this project is to develop and test a culturally and gender-appropriate sexual health education program designed to promote HIV preventive sexual behaviors among African American adolescent females in youth detention centers. The study will be conducted in four stages: (1) adaptation of SiHLE intervention; (2) pilot adapted intervention; (3) revisions to adapted intervention, measures, and implementation; and (4) implementation and evaluation.

We will work closely with the Metro Regional Youth Detention Center (RYDC), in Atlanta, Georgia for all four stages of the project. The first stage, adaptation of SiHLE intervention, will be implemented using data collected from a prior study and with use of Community and Teen Advisory Boards (CAB and TAB). The pilot intervention will be completed with 20 participants from Metro RYDC and will test recruitment and retention strategies, the adapted intervention, and all measures. Revisions will be made based on findings from the pilot. For stage four, implementation and evaluation, we propose to recruit 350 unmarried African American adolescent females, 13-17 years of age, from Metro RYDC. While at the Metro RYDC, adolescents will be invited to participate in the proposed study. All adolescents will be required to have verbal informed parental/guardian consent and complete signed assent forms. Adolescents who are eligible and willing to participate in the project will complete an initial survey conducted on a computer(ACASI). The survey is designed to assess adolescents' sexual risk and preventive behaviors. After they complete the survey, adolescents will then be assigned, by chance alone, to receive either the adapted SiHLE intervention or the control condition. All adolescents will complete 3 individual sessions implemented by an African American health educator.

As we anticipate the participants will be released prior to the follow-up assessment, adolescents will come to a central community site to complete follow-up interviews at 3 and 6-months after completing their initial survey. We will also obtain a self-collected vaginal swab specimen to test for chlamydia and gonorrhea. We will compare the new adapted SiHLE intervention, IMARA, to the control condition in its ability to maintain or enhance adolescents' use of HIV prevention behaviors. If successful, the findings could have important implications for HIV prevention in this vulnerable population.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 188 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: IMARA, Adapting SiHLE for Detained African American Adolescent Females
Study Start Date : October 2008
Actual Primary Completion Date : August 2012
Actual Study Completion Date : August 2012

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
No Intervention: 2
Experimental: Intervention
IMARA HIV Prevention Intervention. Three individual sessions for incarcerated female teens.
Behavioral: IMARA HIV Prevention Intervention
Three individual sessions- behavioral intervention for incarcerated female adolescents.

Primary Outcome Measures :
  1. Proportion of condom protected vaginal sex acts over the last 90 days [ Time Frame: 3 and 6 months post-randomization ]

Secondary Outcome Measures :
  1. Incident infection of chlamydia or gonorrhea as confirmed by laboratory PCR testing [ Time Frame: 3 and 6 months post-randomization ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   13 Years to 17 Years   (Child)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Female
  • African American
  • Ages 13-17
  • Sexually experienced
  • Incarcerated at least 2 days and released to a non-restrictive setting
  • Parent/guardian consent
  • Assent

Exclusion Criteria:

  • Married
  • Pregnant

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00746369

Layout table for location information
United States, Georgia
Metro Regional Youth Detention Center
Atlanta, Georgia, United States, 30316
Sponsors and Collaborators
Emory University
Centers for Disease Control and Prevention
Layout table for investigator information
Principal Investigator: Ralph J. DiClemente, PhD Emory University
Layout table for additonal information
Responsible Party: Ralph J. DiClemente, Professor, Emory University Identifier: NCT00746369    
Other Study ID Numbers: IRB00005355
5UR6PS000679 ( U.S. NIH Grant/Contract )
First Posted: September 4, 2008    Key Record Dates
Last Update Posted: November 19, 2013
Last Verified: May 2013
Keywords provided by Ralph J. DiClemente, Emory University:
HIV Seronegativity
Additional relevant MeSH terms:
Layout table for MeSH terms
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases